This site is part of the Informa Connect Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 3099067.

TIDES USA: Oligonucleotide & Peptide Therapeutics

Early Savings Deadline Expires In:

  • 00
  • 00
  • 00
  • 00
Delivered as a Hybrid Event
May 9-12, 2022 | In-Person + DigitalHynes Convention Center, Boston

Marc Jacob, Ph.D.
Director of Business Development at Ampac Analytical Laboratories Services


Marc recently join Ampac Analytical as Director of Business Development. Ampac Analytical provide state of the art analytical services for the pharmaceutical industry. Before joining Ampac, Marc was working with Phenomenex (a Danaher Company) as Business Development Manager for Prep and Bulk Products from 2017 to 2020 and as Global Product Manager for chiral and preparative chromatography products from 2011 to 2017. Before moving to Phenomenex, Marc was Director of Process Development with Bachem where he led efforts to develop and produce peptide and oligonucleotides Active Pharmaceutical Ingredients. Prior to Bachem, he worked for various contract manufacturing organizations in the research, development and manufacturing of small molecules such as chiral amino acids and other chiral compounds.

Dr. Jacob earned his Doctorate in Synthetic Organic Chemistry at the University of Montpellier, France in 1996 with an emphasis on asymmetric synthesis of amino acids and subsequently completed a postdoc at Texas A&M University under the supervision of Sir Derek Barton (Nobel Laureate 1969).

Agenda Sessions

  • Workshop Moderator’s Welcome and Opening Remarks

  • Closing Remarks and Discussion